Skip to main content

Table 3 Individual and combined WMD, ORs and 95% CIs by IGF-I and IGFBP-3

From: IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies

References IGF-1 IGFBP-3
  WMD(95%CI) OR(95%CI) WMD(95%CI) OR(95%CI)
[14] --- 0.54(0.14,2.07) --- 0.90(0.28,2.85)
[15] -4.00(-10.71,2.71) 0.86(0.47,1.57) -70.00(-141.14,1.14) 0.50(0.25,1.02)
[16] 5.00(-5.65,15.65) 0.64(0.3,11.33) 1300.00(-259.41,2859.41) 2.35(1.13,4.92)
[17] -2.00(-9.69,5.69) 1.74(1.08,2.81) -210.00(-332.13,-87.87) 0.67(0.45,1.01)
[18] -8.30(-17.16,0.56) 0.76(0.39,1.49) -141.00(-250.77,-31.23) 0.71(0.35,1.47)
[19] --- 1.21(0.62,2.35) --- 1.70(0.87,3.30)
Totol effect -3.04(-7.10,1.02) 0.87(0.60,1.13) -112.28(-165.88,-58.68) 0.68(0.48,0.88)
  1. ---, not available.